OBJECTIVE: A Standardized Clinical Assessment and Management Plan (SCAMP) standardizes the care of patients with a predefined diagnosis while actively inviting and collecting data on clinician deviations (DEVs) from its recommendations. For 3 different pediatric cardiac diagnoses managed by SCAMPs, we determined the frequency of, types of, and reasons for DEVs, which are considered to be a valuable source of information and innovation. METHODS: DEVs were collected as part of SCAMP implementation. DEVs were reviewed by the SCAMP committee chairperson and by a separate protocol deviation committee; they were characterized as either justifiable (J), possibly justifiable (PJ), or not justifiable (NJ). RESULTS: We analyzed 415 patients, 484 clinic encounters, and 216 DEVs. Eighty-six (39.8%) of the DEVs were J, 21 (9.7%) were PJ, and 109 (50.4%) were NJ. The percentage of NJ DEVs relative to the number of opportunities for DEV was 4.1%. J and PJ DEVs were mostly due to management of unrelated conditions (11% overall) or special circumstances (22% overall). NJ DEVs primarily involved follow-up intervals (66%) and deleted tests (24%). The reason for deviating from SCAMP recommendations was not given for 31% of DEVs, even though such information was requested. CONCLUSIONS: The overall low rate of NJ DEV suggests that practitioners generally accept SCAMP recommendations, but improved capture of practitioners' reasons for deviating from those recommendations is needed. This analysis revealed multiple opportunities for improving patient care, suggesting that this process can be useful in both promulgating sound practice and evolving improved approaches to patient management.
OBJECTIVE: A Standardized Clinical Assessment and Management Plan (SCAMP) standardizes the care of patients with a predefined diagnosis while actively inviting and collecting data on clinician deviations (DEVs) from its recommendations. For 3 different pediatric cardiac diagnoses managed by SCAMPs, we determined the frequency of, types of, and reasons for DEVs, which are considered to be a valuable source of information and innovation. METHODS: DEVs were collected as part of SCAMP implementation. DEVs were reviewed by the SCAMP committee chairperson and by a separate protocol deviation committee; they were characterized as either justifiable (J), possibly justifiable (PJ), or not justifiable (NJ). RESULTS: We analyzed 415 patients, 484 clinic encounters, and 216 DEVs. Eighty-six (39.8%) of the DEVs were J, 21 (9.7%) were PJ, and 109 (50.4%) were NJ. The percentage of NJ DEVs relative to the number of opportunities for DEV was 4.1%. J and PJ DEVs were mostly due to management of unrelated conditions (11% overall) or special circumstances (22% overall). NJ DEVs primarily involved follow-up intervals (66%) and deleted tests (24%). The reason for deviating from SCAMP recommendations was not given for 31% of DEVs, even though such information was requested. CONCLUSIONS: The overall low rate of NJ DEV suggests that practitioners generally accept SCAMP recommendations, but improved capture of practitioners' reasons for deviating from those recommendations is needed. This analysis revealed multiple opportunities for improving patient care, suggesting that this process can be useful in both promulgating sound practice and evolving improved approaches to patient management.
Authors: Diego Porras; David W Brown; Rahul Rathod; Kevin Friedman; Kimberly Gauvreau; James E Lock; Jesse J Esch; Lisa Bergersen; Audrey C Marshall Journal: Congenit Heart Dis Date: 2013-10-15 Impact factor: 2.007
Authors: Michael Farias; Kathy Jenkins; James Lock; Rahul Rathod; Jane Newburger; David W Bates; Dana G Safran; Kevin Friedman; Josh Greenberg Journal: Health Aff (Millwood) Date: 2013-05 Impact factor: 6.301
Authors: Yvelynne P Kelly; Kavita Mistry; Salman Ahmed; Shimon Shaykevich; Sonali Desai; Stuart R Lipsitz; David E Leaf; Ernest I Mandel; Emily Robinson; Gearoid McMahon; Peter G Czarnecki; David M Charytan; Sushrut S Waikar; Mallika L Mendu Journal: Clin J Am Soc Nephrol Date: 2021-12-15 Impact factor: 8.237
Authors: Yvonne Paris; Olga H Toro-Salazar; Naomi S Gauthier; Kathleen M Rotondo; Lucy Arnold; Rose Hamershock; David E Saudek; David R Fulton; Ashley Renaud; Mark E Alexander Journal: J Am Heart Assoc Date: 2016-02-19 Impact factor: 5.501
Authors: Annemieke A J Konijnendijk; Magda M Boere-Boonekamp; Maria E Haasnoot; Ariana Need Journal: BMC Med Inform Decis Mak Date: 2019-08-15 Impact factor: 2.796